Skip to main content
. 2024 Feb 9;36(1):29. doi: 10.1007/s40520-023-02656-9

Table 1.

Characteristics of participants according to different stages of sarcopenia

Non-sarcopenia
n=2291
Normal-sarcopenia
n=354
Severe-sarcopenia
n=242
P
Assessment of sarcopenia
ASMI (kg/m2) 7.16 (7.10–7.21) 5.90 (5.82–5.98) 5.72 (5.62–5.82) <0.001
Grip strength (kg) 26.3 (26.0–26.7) 23.4 (22.7–24.0) 19.0 (18.4–19.7) <0.001
gait speed (m/s) 1.06 (1.05–1.07) 1.00 (0.98–1.02) 0.83 (0.81–0.85) <0.001
Demographics
Age (years) 71.2 (71.0–71.4) 73.5 (72.9–74.1) 77.4 (76.6–78.1) <0.001
Males, n (%) 1104 (48.2) 203 (52.2) 138 (57.0) <0.001
Body mass index (kg/m2) 24.8 (24.7–25.0) 21.9 (21.6–22.2) 21.8 (21.4–22.3) <0.001
Waist circumference (cm) 84.2 (83.8–84.6) 78.1 (77.2–79.1) 78.6 (77.4–79.8) <0.001
Marriage status (%) 0.001
Married, n (%) 1941 (84.7) 280 (79.1) 180 (74.4)
Unmarried, n (%) 40 (1.7) 11 (3.1) 6 (2.5)
Divorce, n (%) 4 (0.2) 1 (0.3) /
Widowed, n (%) 306 (13.4) 62 (17.5) 56 (23.1)
Residency <0.001
Live alone, n (%) 344 (15.0) 74 (20.9) 51 (21.1)
Live with spouse, n (%) 1428 (62.3) 191 (54.0) 108 (44.6)
Live with children, n (%) 195 (8.5) 36 (10.2) 48 (20.0)
Live with spouse and children, n (%) 324 (14.1) 53 (15.0) 35 (14.5)
Income sources <0.001
Pension, n (%) 69 (3.0) 12 (3.4) 4 (1.7)
Child supply, n (%) 125 (5.5) 28 (7.9) 24 (9.9)
Spouse supply, n (%) 49 (2.1) 6 (1.7) 2 (0.8)
Government assistance, n (%) 30 (1.3) 10 (2.8) 15 (6.2)
Social endowment insurance, n (%) 623 (27.2) 91 (25.7) 68 (28.1)
Others, n (%) 80 (3.49) 11 (3.1) 5 (2.1)
Any two items, n (%) 1315 (57.4) 196 (55.4) 124 (51.2)
Payment methods for medical expenses 0.724
Basic medical insurance for urban residents, n (%) 20 (0.9) 4 (1.1) 1 (0.4)
Basic medical insurance for urban employees, n (%) 52 (2.3) 4 (1.1) 5 (2.1)
All at own expense, n (%) 3 (0.1) 1 (0.3) /
New rural cooperative medical care, n (%) 2216 (96.7) 345 (97.5) 236 (97.5)
Comorbidities
Hypertension, n (%) 889 (38.8) 99 (28.0) 86 (35.5) <0.001
Diabetes mellitus, n (%) 252 (11.0) 20 (5.7) 24 (9.9) 0.008
Lab panel
Total cholesterol (mmol/L) 4.78 (4.73–4.83) 4.80 (4.68–4.92) 4.70 (4.55–4.85) 0.544
Triglycerides (mmol/L) 1.62 (1.58–1.67) 1.36 (1.29–1.44) 1.57 (1.15–1.99) <0.001
High-density lipoprotein (mmol/L) 1.48 (1.46–1.49) 1.56 (1.53–1.60) 1.56 (1.51–1.61) <0.001
Low-density lipoprotein (mmol/L) 2.10 (2.07–2.12) 2.09 (2.02–2.16) 2.03 (1.95–2.11) 0.343
Fasting glucose (mmol/L) 5.82 (5.76–5.87) 5.66 (5.49–5.83) 5.68 (5.49–5.87) 0.073
Alanine aminotransferase (U/L) 19.6 (18.9–20.2) 15.7 (14.6–16.8) 15.9 (14.2–17.6) <0.001
Aspartate aminotransferase (U/L) 25.3 (24.8–25.8) 24.5 (23.5–25.6) 26.0 (23.9–28.0) 0.320
Total bilirubin (μmol/L) 13.8 (13.6–14.1) 13.4 (12.8–14.0) 13.2 (12.4–14.0) 0.221
Hemoglobin (g/L) 129.9 (129.3–130.4) 127.7 (126.2–129.2) 125.3 (123.4–127.3) <0.001
Platelet (×109/L) 146.7 (144.6–148.7) 142.1 (137.2–147.0) 152.7 (145.1–160.2) 0.052
Leukocyte (×109/L) 5.54 (5.48–5.60) 5.45 (5.28–5.61) 5.60 (5.37–5.83) 0.498

Continuous variables were reported as median with interquartile range

ASMI appendicular muscle mass index